A Phase II Study of Telisotuzumab Vedotin in Patients With...

  • Main
  • 2020 / 10
  • A Phase II Study of Telisotuzumab Vedotin in Patients With...
Clinical Lung Cancer 2020 / 10

A Phase II Study of Telisotuzumab Vedotin in Patients With c–MET-positive Stage IV or Recurrent Squamous Cell Lung Cancer (LUNG-MAP Sub-study S1400K, NCT03574753)

Waqar, Saiama N., Redman, Mary W., Arnold, Susanne M., Hirsch, Fred R., Mack, Philip C., Schwartz, Lawrence H., Gandara, David R., Stinchcombe, Thomas E., Leighl, Natasha B., Ramalingam, Suresh S., Ta
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Clinical Lung Cancer
DOI:
10.1016/j.cllc.2020.09.013
Date:
October, 2020
File:
PDF, 135 KB
2020
Conversion to is in progress
Conversion to is failed